Indication

PHD2 Erythrocytosis

1 clinical trial

1 product

Clinical trial

Phase 1 Study of Digoxin for Congenital Erythrocytosis Due to Up-Regulated Hypoxia Sensing

Status: Withdrawn, Estimated PCD: 2024-12-31

Product